dCTPase-IN-1
dCTPase-IN-1 is a highly selective deoxycytidine triphosphate pyrophosphatase 1 (dCTPase) inhibitor with an IC50 of 20 nM. dCTPase-IN-1 functionally inhibits dCTPase, exhibits a synergistic effect in enhancing cytotoxicity, and has no inherent cytotoxicity. dCTPase-IN-1 can be used for the research of leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 353287-72-6
- Formule: C15H12N4O2S2
- Masse moléculaire:344.41
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis
More
Activité biologique
dCTPase-IN-1 (compound 18) (1.0-5.0 μM; 72 h) acts synergistically with 5-Azacytidine (HY-10586) to reduce the viability of human leukemia HL60 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HL60 human leukemia cells
-
Concentration:1.0, 2.5, 5.0 μM (in combination with 2.5 μM 5-Azacytidine)
-
Incubation Time:72 h
-
Result:Synergistically increased the cytotoxicity of 5-Azacytidine, reducing HL60 cell viability without exhibiting cytotoxicity when used alone.
Chemical Information
-
CAS No. 353287-72-6
-
Masse moléculaire 344.41
-
Formule C15H12N4O2S2
-
SMILES
N=1N=C(C=2SC=CC2)N3N=C(SC13)C=4C=CC(OC)=C(OC)C4
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)